Heart Failure Course Bundle

A track that had to be rewritten

We rebuilt the Heart Failure track from scratch rather than updating it, because the subject changed underneath the old version. Four-pillar therapy, the SGLT2 inhibitor evidence extending across the ejection fraction range, the end of therapeutic nihilism in HFpEF, the redefinition of device candidacy — a course teaching the previous consensus is not merely dated, it is teaching a different disease.

These volumes are the set texts for the rebuilt track.

Therapy taught as sequencing, not as a list

The central teaching problem in heart failure is not which drugs to use — every learner can name the four pillars — but the order, the titration pace, and what to sacrifice when blood pressure or renal function will not tolerate all four. Our modules are built around that question and so are the corresponding chapters.

Case work runs on real trajectories: the patient whose creatinine rises on decongestion, the patient whose blood pressure will not permit a fourth agent, the patient who is not decompensated but in low output and has been mislabelled.

Module blocks

Diagnosis and phenotyping, including natriuretic peptide thresholds that shift with obesity and atrial fibrillation. Guideline-directed therapy and titration. Acute decompensation, congestion phenotypes and sequential nephron blockade. Devices — ICD and CRT candidacy against the DANISH-era evidence, and cardiac contractility modulation. Advanced therapy referral, taught as a timing decision because outcome depends on referring before end-organ damage rather than after. Comorbidity: renal disease, iron deficiency, atrial fibrillation, amyloid, diabetes.

Cohort

Cardiology trainees and consultants, heart failure nurse specialists, internal medicine physicians, and learners taking the track for CPD credit.

Access

PDF bundle with lifetime access from CardiologyBooks.com.